- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Snapshot for Actavis Inc (ACT)
| Open: | 127.8000 | Day's Range: | 126.6300 - 131.2400 | Volume: | 3,591,922 |
|---|---|---|---|---|---|
| Previous Close: | 125.5000 | 52wk Range: | 67.6720 - 131.0500 | 1-Yr Rtn: | +87.13% |
Key Statistics for ACT
| Current P/E Ratio (ttm) | 48.8346 |
|---|---|
| Estimated P/E(12/2013) | 15.5606 |
| Relative P/E vs. SPX | 3.0142 |
| Earnings Per Share (USD) (ttm) | 2.6600 |
| Est. EPS (USD) (12/2013) | 8.3480 |
| Est. PEG Ratio | 1.3795 |
| Market Cap (M USD) | 17,315.67 |
| Shares Outstanding (M) | 133.30 |
| 30 Day Average Volume | 1,721,885 |
| Price/Book (mrq) | 4.6343 |
| Price/Sale (ttm) | 2.6482 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ACT
Company Profile & Key Executives for ACT
Actavis Inc. is a generic drug manufacturer providing health care to consumers across the United States.
| Paul M BisaroPresident/CEO | R Todd JoyceChief Financial Ofcr:Global |
| David A BuchenChief Legal Ofcr:Global | Charles M MayrChief Communications Ofcr:Global |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ACT News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page